Visual Perception in Schizophrenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Rochester
About this trial
This study aims to identify novel markers of psychosis using electroencephalography (EEG).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All Subjects
Aged 18-65
20/32 visual acuity or better (using in-house optical correction, if necessary)
An ability to speak English well enough to complete study assessments and to consent to the study
Disqualifiers
All subjects
Subject cannot read and understand the instructions well enough to complete the tasks or cannot provide informed consent.
Intellectual impairment (WRAT-5 score < 70) (at the discretion of experimenter);
Actively intoxicated, as shown via patient self-report or staff report;
Trial design
Design model
Single group
Treatments tested in this trial
EEG measure of visual processing
Other interventionNon-invasive scalp EEG measure of early cortical visual processing.
Treatment groups
84 Participants
are divided into 1 treatment groupGroup A: All participantsExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
mean amplitude of EEG visual response
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Rochester
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov